Konig Szynka Tilmann Von Renesse Dusseldorf patent opposition analysis

The comprehensive analysis of Konig Szynka Tilmann Von Renesse Dusseldorf opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Konig Szynka Tilmann Von Renesse Dusseldorf

Patent NumberTitleApplicantOpposition DateOpposition Company
Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHMEJun 1, 2022KONIG SZYNKA TILMANN VON RENESSE
Methods And Systems For Processing A Cell CultureGENZYMEMay 18, 2022KONIG SZYNKA TILMANN VON RENESSE
Binding Molecules Specific For Cd73 And Uses ThereofMEDIMMUNENov 12, 2021KONIG SZYNKA TILMANN VON RENESSE
Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants ThereofGENENTECHNov 8, 2021HEXAL
Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITYOct 14, 2021KONIG SZYNKA TILMANN VON RENESSE
Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their UsesJANSSEN BIOTECHOct 6, 2021KONIG SZYNKA TILMANN VON RENESSE
Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-RadiationsSTADA ARZNEIMITTELSep 3, 2021MULLER HANDELS
Recombinant Adeno-Associated Virus Particle Purification Comprising An Affinity Purification StepASSOCIATION FRANAISE CONTRE LES MYOPATHIESAug 25, 2021KONIG SZYNKA TILMANN VON RENESSE
A Method For Treating Lignin And For Producing A Binder CompositionUPM KYMMENEJul 28, 2021SURFACTOR GERMANY
Retroviral Transduction Using PoloxamersREVVITY GENE DELIVERYJul 27, 2021KONIG SZYNKA TILMANN VON RENESSE

Top companies who are the clients of Konig Szynka Tilmann Von Renesse Dusseldorf